Skip to content

Clinical trials

Phase 1/2 Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 1/2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20092
20101
20112
20122
20151
20161
20192
20211
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Withdrawn5
Terminated3
Not yet recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
35Pharma Inc1
AdventHealth1
Ann & Robert H Lurie Children's Hospital of Chicago1
Assiut University1
Attgeno AB1
Chan, Stephen, MD, PhD1
Duke University1
Fundación Neumologica Colombiana1
Imperial College London1
Joan Albert Barbera Mir1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary20
Heart Defects, Congenital2
Anemia, Sickle Cell1
Bronchopulmonary Dysplasia1
COVID-191
Cardiovascular Diseases1
Heart Diseases1
Heart Failure1
Lung Diseases1
Lung Diseases, Interstitial1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.